Guardado en:
Detalles Bibliográficos
Autores principales: Jakob F. B. Schwensen, Wolfgang Uter, Olivier Aerts, Tove Agner, Richard Brans, Magnus Bruze, Caterina Foti, Ana Maria Giménez‐Arnau, Margarida Gonçalo, Cecilia Svedman, Luca Stingeni, Mark Wilkinson, Jeanne Duus Johansen
Formato: Artículo Open Access
Publicado: Wiley 2024
Materias:
Acceso en línea:https://onlinelibrary.wiley.com/doi/10.1111/cod.14641
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1867020368726720512
author Jakob F. B. Schwensen
Wolfgang Uter
Olivier Aerts
Tove Agner
Richard Brans
Magnus Bruze
Caterina Foti
Ana Maria Giménez‐Arnau
Margarida Gonçalo
Cecilia Svedman
Luca Stingeni
Mark Wilkinson
Jeanne Duus Johansen
author_facet Jakob F. B. Schwensen
Wolfgang Uter
Olivier Aerts
Tove Agner
Richard Brans
Magnus Bruze
Caterina Foti
Ana Maria Giménez‐Arnau
Margarida Gonçalo
Cecilia Svedman
Luca Stingeni
Mark Wilkinson
Jeanne Duus Johansen
Jakob F. B. Schwensen
Wolfgang Uter
Olivier Aerts
Tove Agner
Richard Brans
Magnus Bruze
Caterina Foti
Ana Maria Giménez‐Arnau
Margarida Gonçalo
Cecilia Svedman
Luca Stingeni
Mark Wilkinson
Jeanne Duus Johansen
collection Wiley Open Access
contents Current frequency of contact allergy to isothiazolinones (methyl‐, benz‐ and octylisothiazolinone) across Europe Jakob F. B. Schwensen Wolfgang Uter Olivier Aerts Tove Agner Richard Brans Magnus Bruze Caterina Foti Ana Maria Giménez‐Arnau Margarida Gonçalo Cecilia Svedman Luca Stingeni Mark Wilkinson Jeanne Duus Johansen Contact Dermatitis AbstractBackgroundThe use of methylisothiazolinone (MI) as a preservative in cosmetic products caused an alarming increase in MI contact allergy across Europe in the 2010s. This was followed by regulations of use with a total ban on leave‐on (implemented in 2017) and reduced use concentrations in rinse‐off cosmetics (2018).ObjectiveTo follow‐up on the prevalence of contact allergy to MI and the related benzisothiazolinone (BIT) and octylisothiazolinone (OIT) in consecutively patch‐tested patients in Europe.MethodsA cross‐sectional audit following the design of two previous audits on MI contact allergy from 1 May 2022 to 31 October 2022 included all patients patch tested with the European baseline series, including or supplemented with MI, BIT and OIT across 10 departments in eight European countries.ResultsA total of 2554 patients were consecutively patch tested with the three isothiazolinones during the study period. The prevalence of MI and BIT contact allergy was 2.9% (95% confidence interval [CI]: 2.3%–3.7%; range 1.1%–5.8%) and 3.1% (95% CI: 2.4%–3.9%; range 0.0%–6.6%), respectively; that of OIT was 0.7% (95% CI: 0.4%–1.1%; range 0%–3.2%). Rinse‐off cosmetic (73.3%) and leave‐on cosmetic products (13.3%) were still associated with eliciting allergic contact dermatitis to MI.ConclusionWe confirmed a positive impact of regulatory measures on the prevalence of MI contact allergy in Europe, which halved compared to 2015. However, our data suggest that consumers may still be exposed to older cosmetic products containing MI. BIT has superseded MI in causing contact allergy, despite not being allowed for use in cosmetic products. 10.1111/cod.14641 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1111/cod.14641
format Artículo Open Access
id wiley_oa_10_1111_cod_14641
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle Current frequency of contact allergy to isothiazolinones (methyl‐, benz‐ and octylisothiazolinone) across Europe
Jakob F. B. Schwensen
Wolfgang Uter
Olivier Aerts
Tove Agner
Richard Brans
Magnus Bruze
Caterina Foti
Ana Maria Giménez‐Arnau
Margarida Gonçalo
Cecilia Svedman
Luca Stingeni
Mark Wilkinson
Jeanne Duus Johansen
Contact Dermatitis
Current frequency of contact allergy to isothiazolinones (methyl‐, benz‐ and octylisothiazolinone) across Europe Jakob F. B. Schwensen Wolfgang Uter Olivier Aerts Tove Agner Richard Brans Magnus Bruze Caterina Foti Ana Maria Giménez‐Arnau Margarida Gonçalo Cecilia Svedman Luca Stingeni Mark Wilkinson Jeanne Duus Johansen Contact Dermatitis AbstractBackgroundThe use of methylisothiazolinone (MI) as a preservative in cosmetic products caused an alarming increase in MI contact allergy across Europe in the 2010s. This was followed by regulations of use with a total ban on leave‐on (implemented in 2017) and reduced use concentrations in rinse‐off cosmetics (2018).ObjectiveTo follow‐up on the prevalence of contact allergy to MI and the related benzisothiazolinone (BIT) and octylisothiazolinone (OIT) in consecutively patch‐tested patients in Europe.MethodsA cross‐sectional audit following the design of two previous audits on MI contact allergy from 1 May 2022 to 31 October 2022 included all patients patch tested with the European baseline series, including or supplemented with MI, BIT and OIT across 10 departments in eight European countries.ResultsA total of 2554 patients were consecutively patch tested with the three isothiazolinones during the study period. The prevalence of MI and BIT contact allergy was 2.9% (95% confidence interval [CI]: 2.3%–3.7%; range 1.1%–5.8%) and 3.1% (95% CI: 2.4%–3.9%; range 0.0%–6.6%), respectively; that of OIT was 0.7% (95% CI: 0.4%–1.1%; range 0%–3.2%). Rinse‐off cosmetic (73.3%) and leave‐on cosmetic products (13.3%) were still associated with eliciting allergic contact dermatitis to MI.ConclusionWe confirmed a positive impact of regulatory measures on the prevalence of MI contact allergy in Europe, which halved compared to 2015. However, our data suggest that consumers may still be exposed to older cosmetic products containing MI. BIT has superseded MI in causing contact allergy, despite not being allowed for use in cosmetic products. 10.1111/cod.14641 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Current frequency of contact allergy to isothiazolinones (methyl‐, benz‐ and octylisothiazolinone) across Europe
topic Contact Dermatitis
url https://onlinelibrary.wiley.com/doi/10.1111/cod.14641